Related references
Note: Only part of the references are listed.Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the united states during the era of widespread PCV7 vaccination, 1998-2004
Lauri A. Hicks et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
Rosalyn J. Singleton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Candidate live, attenuated Salmonella enterica serotype typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines
Moataz Abd El Ghany et al.
INFECTION AND IMMUNITY (2007)
Differential effect of auxotrophies on the release of macromolecules by Salmonella enterica vaccine strains
Holger Loessner et al.
FEMS MICROBIOLOGY LETTERS (2006)
Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella entetica serovar Typhimurium
HS Garmory et al.
INFECTION AND IMMUNITY (2005)
Bacteria-mediated DNA transfer in gene therapy and vaccination
H Loessner et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Clinical effectiveness of seven-valent pneumococcal conjugate vaccine (Prevenaro®) against invasive pneurnococcal diseases:: prospects for children in France
S Black et al.
ARCHIVES DE PEDIATRIE (2004)
Enteric pathogens as vaccine vectors for foreign antigen delivery
CN Kotton et al.
INFECTION AND IMMUNITY (2004)
Simultaneous analyses of neutral carbohydrates and amino sugars in freshwaters with HPLC-PAD
XH Cheng et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2003)
Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization
HY Kang et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine
HY Kang et al.
INFECTION AND IMMUNITY (2002)
Use of live bacterial vaccine vectors for antigen delivery:: potential and limitations
E Medina et al.
VACCINE (2001)
Type 1 type 2 immunity in infectious diseases
B Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2001)
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
DE Briles et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
